| 000 | 01565 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513085335.0 | ||
| 264 | 0 | _c19960327 | |
| 008 | 199603s 0 0 eng d | ||
| 022 | _a0036-5548 | ||
| 024 | 7 |
_a10.3109/00365549509047041 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHökeberg, I | |
| 245 | 0 | 0 |
_aDiagnostic markers and risk factors of cytomegalovirus infection and disease in renal allograft recipients. _h[electronic resource] |
| 260 |
_bScandinavian journal of infectious diseases _c1995 |
||
| 300 |
_a435-40 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 |
_aArthralgia _xetiology |
| 650 | 0 | 4 |
_aCytomegalovirus _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 |
_aViremia _xetiology |
| 700 | 1 | _aEriksson, B M | |
| 700 | 1 | _aZweygberg-Wirgart, B | |
| 700 | 1 | _aTufvesson, G | |
| 700 | 1 | _aOlding-Stenkvist, E | |
| 700 | 1 | _aGrillner, L | |
| 773 | 0 |
_tScandinavian journal of infectious diseases _gvol. 27 _gno. 5 _gp. 435-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/00365549509047041 _zAvailable from publisher's website |
| 999 |
_c8587181 _d8587181 |
||